Mapmygenome brings down cost of genetic testing dramatically with Sugargene™
Hyderabad, India, November 28, 2014: Mapmygenome launched a new low cost personal genomics test, Sugargene™on November 27, 2014 . Sugargene™ is a personal genomics test to understand the genetic risk of type 2 diabetes and obesity, nutrigenetics, and management options.
With this test, Mapmygenome aims to bring about lifestyle changes that can help people achieve optimum health and save on expensive treatments.
Anu Acharya, CEO of Mapmygenome, said, “Most of us have at least one person in the family suffering from Diabetes and have seen how it painfully attacks the rest of the body. Diabetes is preventable but intervention must be done early. We listened to our customers and ensured that Sugargene is affordable for all and will provide both fun facts as well as a plan to work on towards a healthier life.
We aim to combat two greatest global epidemics of our time – Obesity and Type 2 Diabetes.”
Sugargene™ costs INR 2999. This test analyses DNA for genetic predisposition to type 2 diabetes and obesity; key traits related to nutrigenetics such as satiety levels, sugar cravings, and more; and prevention and treatment options.
Mapmygenome is a molecular diagnostics company for people who are proactive about their health. Their products provide insights into the genetic basis of individuals’ health, including traits, lifestyle, drug responses, inherited conditions, and diseases. By combining genetic report and health history with genetic counseling, Mapmygenome provides actionable steps for individuals and their physicians towards a healthier life.
In addition to personal genomics, Mapmygenome offers solutions in brain wellness and molecular diagnostics. The Molecular Diagnostic portfolio include NGS panels on rare disorders, Thalassemia, Cystic Fibrosis, Muscular Dystrophy, etc. For a complete listing please see https://mapmygenome.in/personal-genomics
For more information, visit https://mapmygenome.in